Advertisement

Topics

Companies Related to "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" [Most Relevant Company Matches] - Page: 4 RSS

11:45 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" found in our extensive corporate database of over 50,000 company records.

Showing "Monoclonal Antibody Therapy Vaccine Therapy Treating Patients With" Companies 76–100 of 5,500+

Relevant

Genetix Pharmaceuticals, Inc.

Genetix Pharmaceuticals, Inc. is an emerging leader in treatments for severe genetic disorders based on a breakthrough gene therapy platform that uses a patient’s own genes to treat his/her disorder. Taking stem cells from a patient’s own bone marrow, Genetix uses a proprietary lentiviral technology to modify the genes and deliver corrective stem ...


Bioquest

Bioquest offer a range of contract antibody production services for both monoclonal and polyclonal antibodies. We also have a range of unusual antibody reagents available.antibodies to steroids and moreContract antibody manufacturer of monoclonals, polycl

Cyberonics, Inc.

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the...


NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

Pocono

Custom Polyclonal and Monoclonal Antibody Productionspecializing in: Rabbits Rats Guinea Pigs Mice Goats Chickens Sheep Contract antibody manufacturer of monoclonals, polyclonals

The Vaccine and Gene Therapy Institute of Florida (VGTI Florida)

“We dedicate ourselves every single day to finding novel treatments for chronic diseases like cancer and HIV/AIDS,” said Mel Rothberg, Chief Operating Officer, VGTI Florida. “We’re pleased to have Catherine onboard. By leading our business development efforts, she will facilitate the commercial translation of therapeutic discoveries so that ...

A&G Pharmaceutical, Inc.

A&G was incorporated in Delaware as a “C” Corporation on June 6, 2000. The company is located in Columbia, Maryland and has 12 employees occupying 6,725 square feet of lab space. A&G has raised $3.5 million in capital to date and is looking to finish clinical trials and FDA submission for 2 diagnostic kits for breast cancer. Besides our own theranostic product development, A&G has a unique pro...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmune disorders through Intravenous Immunoglobulin (“IVIG”) therapy, as well as hemophilia and Rheumatoid Arthritis. In addition to filling a patient’s prescriptions, Biomedâ...

ARIUS Research Inc.

ARIUS Research Inc. is a biotechnology company dedicated to personalizing cancer therapy through the discovery and development of novel anticancer monoclonal antibodies (MAbs). Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST™, that rapidly identifies powerful MAbs targeting a variety of cancer indications. This antibody generation engine has enabled ARIUS to...

Samson Showalter Lepore Vascular Specialists

Our practice is the only medical practice in the Tri-county area dedicated to the treatment of patients with disorders of the veins and arteries, the Vascular System. Unlike most vascular surgical groups, we are also uniquely trained and experienced to offer all forms of diagnosis and therapy including:medications exercise therapy endovascular diagnosis and treatments (Angiography, Balloon angiopl...

Neurogene, Inc.

Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring therapies to patients that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatmen...

GammaCan

GammaCan is a biopharmaceutical company focused on clinical-phase development and commercialization. GammaCan’s initial therapy under development is a first-in-class anti-cancer immunotherapy aimed at preventing metastasis (the spread of cancer to other parts of the body) of a variety of cancers. GammaCan’s first product was entered to phase-II clinical trials.GammaCan’s innovative treatment...

U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. (NASDAQ:USPH) operates 369 clinics in 43 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, non-surgical treatment of osteoarthritis, treatment for neurologically-related injuries and rehabilitation of injured work...

Texas Center for Proton Therapy

Texas Center for Proton Therapy is the North Texas region’s first proton therapy center. The center features latest-generation technology, including pencil-beam scanning and image-guided proton therapy, providing precise radiation treatment with the opportunity to reduce side effects. Opening in late 2015, the facility will provide advanced cancer tre...

Myonexus Therapeutics

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a leader in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics’ pipeline includes three clinical stage g...

WSPT

WSPT is the Bronx's world-class location for Physical Therapy, Aquatic Therapy, and Wellness. Their 11,000 square foot facility is equipped with state-of-the-art rehab equipment, a full yoga/pilates/dance studio, and a Hydroworx Aquatic Therapy Pool with built-in treadmill. WSPT - world-class care, right around the corner. For more information about WSPT, please visit - www.wspt.org

Greenbrook TMS Inc.

Operating through 47 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with...

Maxinovel Pharmaceuticals, Inc.

Maxinovel Pharmaceuticals, Inc. is a biotech company focusing on the discovery and development of Immuno-oncology therapy and targeted therapy. It will use its orally active Immuno-oncology product platform to bring effective combo product of multi-components in a single oral pill to the patients worldwide. For more info: www.maxinovel.com

Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...

Collateral Therapeutics Incorporated

Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process which results in the growth of additional blood vessels, to increase levels of blood flow to oxygen-deprived tissues. The Company's angiogenic products are administered using methods of gene therapy based on non-surgical adenoviral vector delive...

Critical Homecare Solutions

CHS is a leading provider of comprehensive home infusion therapy and specialty infusion services to patients suffering from acute or chronic conditions. CHS delivers infusion pharmaceuticals, biopharmaceuticals, nutrients and related services each year to patients in the home through 35 infusion locations in 22 states, primarily in the eastern United States. CHS also provides nursing and therapy v...

ValveXchange, Inc.

ValveXchange, Inc. is focused on developing the “future of heart valve therapy.” The ValveXchange two-part architecture represents the first-of-its-kind "serviceable" bioprosthetic heart valve. By offering periodic, minimally-invasive exchange of worn-out leaflets, patients of all ages can enjoy a full, active lifestyle, avoiding a mechanical val...

Inspiration Biopharmaceuticals

Inspiration Biopharmaceuticals was founded in 2004 with the mission to revolutionize treatments for hemophilia. The Company is focused on developing products that have the potential to broaden patient access to therapy, including prophylactic use. Greater access and more frequent prophylactic therapy have been shown to reduce complications of the disease and enhance patients' long-term health and ...

Nuvelo

Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo's development pipeline includes several acute cardiovascular and oncology programs. The cardiovascular portfolio includes three programs: alfimeprase, a direct acting thr...

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals is a privately held biotechnology company focused on the development of products for oncology and ophthalmology treatment, including agents that inhibit angiogenesis. TRACON addresses unmet needs in these areas with first-in-class product candidates that will complement existing therapies. TRC093 is a monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis...


More From BioPortfolio on "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks